NCT00148915 - A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

Osteoporosis

Interventions

DRUG

ibandronate

DRUG

Placebo

matching placebo

Trial Locations (14)

10993

GSK Investigational Site, West Haverstraw

16635

GSK Investigational Site, Duncansville

20817

GSK Investigational Site, Bathesda

30033

GSK Investigational Site, Decatur

30308

GSK Investigational Site, Atlanta

33143

GSK Investigational Site, Miami

33156

GSK Investigational Site, Miami

46202

GSK Investigational Site, Indianapolis

48532

GSK Investigational Site, Flint

80227

GSK Investigational Site, Lakewood

80304

GSK Investigational Site, Boulder

87106

GSK Investigational Site, Albuquerque

91786

GSK Investigational Site, Upland

04401

GSK Investigational Site, Bangor

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY